We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZG icon
1251
Zillow
ZG
$8.15B
$6.44M 0.01%
206,365
-24,977
-11% -$818K
SBNY
1252
DELISTED
Signature Bank
SBNY
$6.42M 0.01%
55,763
-27,127
-33% -$3.73M
BMO icon
1253
Bank of Montreal
BMO
$129B
$6.41M 0.01%
70,767
-1,687
-2% -$156K
CMC icon
1254
Commercial Metals
CMC
$7.98B
$6.4M 0.01%
132,516
+45,735
+53% +$2.1M
CG icon
1255
Carlyle Group
CG
$18.3B
$6.38M 0.01%
213,903
-6,934
-3% -$198K
HEFA icon
1256
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.81B
$6.38M 0.01%
236,240
-688,854
-74% -$21.1M
DNP icon
1257
DNP Select Income Fund
DNP
$4.11B
$6.37M 0.01%
566,249
+32,392
+6% +$354K
BE icon
1258
Bloom Energy
BE
$69.6B
$6.37M 0.01%
332,976
+38,887
+13% +$764K
CLF icon
1259
Cleveland-Cliffs
CLF
$6.93B
$6.36M 0.01%
394,906
-85,353
-18% -$1.29M
NCNO icon
1260
nCino
NCNO
$2.26B
$6.33M 0.01%
239,363
+17,133
+8% +$482K
CXW icon
1261
CoreCivic
CXW
$3.13B
$6.32M 0.01%
546,703
-12,699
-2% -$141K
ACM icon
1262
Aecom
ACM
$8.19B
$6.32M 0.01%
74,366
-2,193
-3% -$172K
BCPC
1263
Balchem Corp
BCPC
$5.65B
$6.29M 0.01%
51,527
+1,901
+4% +$251K
SNV
1264
DELISTED
Synovus
SNV
$6.28M 0.01%
167,240
-8,883
-5% -$353K
CWAN
1265
DELISTED
Clearwater Analytics
CWAN
$6.28M 0.01%
334,703
+60,419
+22% +$1.05M
DGRS icon
1266
WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund
DGRS
$415M
$6.27M 0.01%
155,909
-799
-0.5% -$32.3K
SEM
1267
DELISTED
Select Medical
SEM
$6.26M 0.01%
467,807
+8,325
+2% +$108K
BMRN icon
1268
BioMarin Pharmaceuticals
BMRN
$13.3B
$6.25M 0.01%
60,409
+2,517
+4% +$236K
SWK icon
1269
Stanley Black & Decker
SWK
$15.4B
$6.24M 0.01%
83,121
-88,100
-51% -$6.88M
TIPX icon
1270
State Street SPDR Bloomberg 1-10 Year TIPS ETF
TIPX
$2.04B
$6.24M 0.01%
338,317
-71,450
-17% -$1.32M
IMTM icon
1271
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.33B
$6.24M 0.01%
+202,437
New +$6.01M
PFHD
1272
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$6.23M 0.01%
224,505
+450
+0.2% +$12.5K
ESS icon
1273
Essex Property Trust
ESS
$18.5B
$6.22M 0.01%
29,342
-4,561
-13% -$997K
ATHM icon
1274
Autohome
ATHM
$2.6B
$6.22M 0.01%
203,160
-12,743
-6% -$379K
TS icon
1275
Tenaris
TS
$26.6B
$6.21M 0.01%
176,744
+167,580
+1,829% +$5.36M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.